000 02765cam a2200337 a 4500
003 EG-GiCUC
005 20250223032520.0
008 200205s2020 ua dho f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.10.M.Sc.2020.Ta.T
100 0 _aTamarah Edries Dhannoon
245 1 0 _aTCA 35% as a novel therapy for patchy alopecia areata in comparison to intralesional steroid /
_cTamarah Edries Dhannoon ; Supervised Doaa Mohamed Aly Mahgoub , Marwa Salah Eldin Elmesidy
246 1 5 _aحمض الخليك ثلاثى الكلور ٣٥{u٠٦٦ء} كنوع علاج جديد للثعلبة البقعية مقارنة بحقن الكورتزون الموضعى
260 _aCairo :
_bTamarah Edries Dhannoon ,
_c2020
300 _a118 P. :
_bcharts , facsimiles , photographs ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology
520 _aBackground: Alopecia Areata (AA) is a common cause of patchy hair loss on the scalp and body. Intralesional corticosteroids (ILCs) is the first-line therapy for patients older than 10 years, however some patients do not respond to glucocorticoid treatment effectively. Also, chemical peels with phenol and lactic acid have been tried successfully in the treatment of alopecia areata. Aim of the work: To evaluate the efficacy of new type of chemical peel (TCA 35%) for the treatment of alopecia areata in comparison to ILCs. Methods: Twenty-two patients with two or more patches of alopecia areata were included in. The mean age of the patients was 25.55 ± 10.62. Two treatment modalities with ILCs and topical TCA 35% were performed in two randomly selected patches. Three sessions were done 3 weeks apart and followed-up for three months. Evaluation was done using Mac Donald Hull and Norris grading system and by counting dermoscopic parameters in each patch. Results: Both ILCs and TCA 35% treated patches showed measurable improvement with no statistically significant difference between the results of the two modalities (p>0.05) at different times of the study. Yellow dots, black dots, exclamation marks and dystrophic hair were all reduced by 100%, 82.0%, 100% and 88.3% in ILCs treated patches and by 70.4%, 69.1%, 100% and 75.0% in TCA treated patches, respectively
530 _aIssued also as CD
653 4 _aAlopecia areata
653 4 _aTCA 35%
653 4 _aTriamcinolone acetonide
700 0 _aDoaa Mohamed Aly Mahgoub ,
_eSupervisor
700 0 _aMarwa Salah Eldin Elmesidy ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c76524
_d76524